Unlocking treatment potential: Identifying the most promising indications for an inhalative novel product in Europe and North America.

By analyzing market dynamics and evaluating the standard of care for various conditions, our client identified the most promising indication for their novel treatment. This allowed them to realign their development strategy and target high-value growth opportunities.

Outcome

  • A detailed understanding of patient demographics, treatment workflows, and the influence of key stakeholders, providing a strategic foundation for targeted market entry and engagement.
  • An in-depth comparison of established and emerging therapies, helping the client anticipate shifts in therapeutic approaches and identify competitive opportunities.
  • Actionable insights into clinical trial endpoints, patient recruitment strategies, and risk factors, enabling more efficient trial planning and improved alignment with real-world clinical applications.

KEY INTELLIGENCE OBJECTIVES

  • Evaluate the total patient population size for each selected indication and examine the competitive landscape of treatments, detailing established therapies and emerging innovations.
  • Analyze the clinical trial pipeline to reveal treatment trends and potential shifts in therapeutic approaches.
  • Identify national and international guidelines defining each indication’s standard of care (SoC), guiding compliance and best practices.
  • Map the patient journey for each indication, highlighting treatment workflows and critical decision points from diagnosis to therapy completion.
  • Pinpoint critical stakeholders in the treatment pathway to understand their roles, influence, and impact on therapy choices and patient outcomes.
  • Identify unmet needs in treatment protocols to uncover gaps and highlight areas for future innovation.
  • Assess clinical trial potential, including risk factors like recruitment challenges that may impede trial progression.
  • Evaluate trial endpoints and characterize target populations, ensuring alignment with clinical objectives and real-world applications.
  • Assess the applicability of novel therapies within existing clinical practices for each selected indication, gauging their market relevance.

Geography

  • Western Europe
  • Central & Eastern Europe
  • Middle East
  • Africa
  • North America
  • South America
  • Other

    • Go back to our case studies

    Welcome to EMBS Group

    Please review the basic information regarding the processing of personal data. The Data Administrator is EMBS GROUP Sp. z o.o. Sp. k. You can contact us via email at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a).

    Please note that any personal data you provide may be used only for the specific purpose for which it was shared. Although providing your data is voluntary, not doing so may limit certain services or actions.

    For more detailed information on processing personal data, including exercising your rights, please refer to our Privacy Policy.

    Accept

    Get the report

    SUBSCRIBE TO MARKET MINDS

    Smart decisions start here.
    Unlock hard-to-get market intelligence to empower your next strategic move.

    Contact us

    Want to talk about your business challenge with us?
    Let us know, we’re always happy to talk.

    EMBS GROUP Sp. z o.o. Sp. k., as the Data Administrator, will process the personal data provided above to respond to the message sent via the form. You can contact us at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a). The full text of the information clause is available in the Privacy Policy.
    Privacy Overview

    EMBS Group, as the Data Administrator, uses cookies to enhance user experience and analyze website traffic. You can change your cookie settings at any time. For more information, please see our Privacy Policy.